ADMA Biologics, Inc. (ADMA)

18.81 +0.47 (+2.56%) USD  |  NASDAQ  |  Jan 07, 16:00
18.81 0.00 (0.00%) After-Hours: 18:01
More

ADMA Biologics Research and Development Expense (Annual): 1.813M for Dec. 31, 2024

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for ADMA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. 74.43M
Aldeyra Therapeutics, Inc. 48.22M
Arcutis Biotherapeutics, Inc. 76.42M
Marker Therapeutics, Inc. 13.47M
CorMedix, Inc. 3.942M